|
names
|
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1{H}-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- 4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide
- Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
- Celebrex
- Celecoxib
- Celecoxib 1.0 mg/ml in Acetonitrile
- Celecoxib, >=98% (HPLC)
- Celecoxib, European Pharmacopoeia (EP) Reference Standard
- Celecoxib (GMP)
- Celecoxib (GMP Like)
- Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material
- Celecoxib (SC 58635)
- Celecoxib (Standard)
- Celecoxib, United States Pharmacopeia (USP) Reference Standard
- Cyclosporin L
|